[go: up one dir, main page]

UA82907C2 - Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromium-6-yl-derivatives, process and intermediates for the preparation thereof and drugs containing said compounds - Google Patents

Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromium-6-yl-derivatives, process and intermediates for the preparation thereof and drugs containing said compounds Download PDF

Info

Publication number
UA82907C2
UA82907C2 UAA200605330A UAA200605330A UA82907C2 UA 82907 C2 UA82907 C2 UA 82907C2 UA A200605330 A UAA200605330 A UA A200605330A UA A200605330 A UAA200605330 A UA A200605330A UA 82907 C2 UA82907 C2 UA 82907C2
Authority
UA
Ukraine
Prior art keywords
compounds
formula
phenyl
dimethyl
dihydro
Prior art date
Application number
UAA200605330A
Other languages
English (en)
Ukrainian (uk)
Inventor
Dieter Ziegler
Reinhard Bruckner
Michael Weske
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of UA82907C2 publication Critical patent/UA82907C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
UAA200605330A 2003-10-17 2004-10-14 Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromium-6-yl-derivatives, process and intermediates for the preparation thereof and drugs containing said compounds UA82907C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10348298A DE10348298A1 (de) 2003-10-17 2003-10-17 Amidomethyl-substituierte 2-(4-Sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-ylderivade, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
PCT/EP2004/052539 WO2005037780A2 (de) 2003-10-17 2004-10-14 Amidomethyl-substituierte 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromen-6-yl-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
UA82907C2 true UA82907C2 (en) 2008-05-26

Family

ID=34442032

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200605330A UA82907C2 (en) 2003-10-17 2004-10-14 Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromium-6-yl-derivatives, process and intermediates for the preparation thereof and drugs containing said compounds

Country Status (24)

Country Link
EP (1) EP1678130B1 (pt)
JP (1) JP4791968B2 (pt)
KR (1) KR20060129170A (pt)
CN (1) CN100532375C (pt)
AR (1) AR046106A1 (pt)
AT (1) ATE405547T1 (pt)
AU (1) AU2004281195B2 (pt)
BR (1) BRPI0415523A (pt)
CA (1) CA2542813C (pt)
DE (3) DE10348298A1 (pt)
DK (1) DK1678130T3 (pt)
ES (1) ES2313126T3 (pt)
HR (1) HRP20080602T3 (pt)
IL (1) IL174950A (pt)
MX (1) MXPA06003958A (pt)
NO (1) NO20062202L (pt)
PL (1) PL1678130T3 (pt)
PT (1) PT1678130E (pt)
RU (1) RU2355685C2 (pt)
SI (1) SI1678130T1 (pt)
TW (1) TWI321564B (pt)
UA (1) UA82907C2 (pt)
WO (1) WO2005037780A2 (pt)
ZA (1) ZA200602788B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7714150B2 (en) 2005-04-12 2010-05-11 Solvay Pharmaceuticals Gmbh Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivatives
ZA200707473B (en) * 2005-04-12 2008-12-31 Solvay Pharm Gmbh Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3 , 4-dihydro-2H-cromen-6-yl derivatives and their use as potassium channel blockers
WO2007015775A2 (en) * 2005-07-22 2007-02-08 Merck & Co., Inc. Potassium channel inhibitors
GB0525164D0 (en) 2005-12-09 2006-01-18 Xention Discovery Ltd Compounds
GB0815784D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815782D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815781D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
NO3175985T3 (pt) 2011-07-01 2018-04-28
WO2013112932A1 (en) 2012-01-27 2013-08-01 Gilead Sciences, Inc. Combination therapies using late sodium ion channel blockers and potassium ion channel blockers
WO2014134419A1 (en) 2013-03-01 2014-09-04 Gilead Sciences, Inc. Use of ikach blockers for the treatment of cardiac diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK281507B6 (sk) * 1992-11-30 2001-04-09 Smithkline Beecham Plc Použitie benzopyránových analógov, benzopyránové analógy, spôsob ich prípravy a farmaceutický prostriedok s ich obsahom
DE19546736A1 (de) * 1995-12-14 1997-06-19 Hoechst Ag Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate
DE19742509A1 (de) * 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
JP2002523451A (ja) * 1998-09-01 2002-07-30 ブリストル−マイヤーズ スクイブ カンパニー カリウムチャネル抑制剤および方法
JP2000336085A (ja) * 1999-03-25 2000-12-05 Nissan Chem Ind Ltd クロマン誘導体
AU2830800A (en) * 1999-03-25 2000-10-16 Nissan Chemical Industries Ltd. Chroman derivatives
AU781365B2 (en) * 1999-12-21 2005-05-19 Icagen, Inc. Potassium channel inhibitors

Also Published As

Publication number Publication date
BRPI0415523A (pt) 2006-12-26
AU2004281195A2 (en) 2005-04-28
AU2004281195A1 (en) 2005-04-28
AU2004281195B2 (en) 2010-12-16
PL1678130T3 (pl) 2009-01-30
IL174950A0 (en) 2006-08-20
JP4791968B2 (ja) 2011-10-12
TW200523259A (en) 2005-07-16
WO2005037780A2 (de) 2005-04-28
CN1894233A (zh) 2007-01-10
ES2313126T3 (es) 2009-03-01
DE10348298A1 (de) 2005-05-19
IL174950A (en) 2010-06-30
HK1096960A1 (en) 2007-06-15
CN100532375C (zh) 2009-08-26
ATE405547T1 (de) 2008-09-15
NO20062202L (no) 2006-07-03
MXPA06003958A (es) 2006-07-05
CA2542813A1 (en) 2005-04-28
KR20060129170A (ko) 2006-12-15
AR046106A1 (es) 2005-11-23
EP1678130A2 (de) 2006-07-12
ZA200602788B (en) 2008-01-30
HRP20080602T3 (hr) 2008-12-31
DE502004007916D1 (de) 2008-10-02
EP1678130B1 (de) 2008-08-20
TWI321564B (en) 2010-03-11
WO2005037780A3 (de) 2007-10-18
SI1678130T1 (sl) 2008-12-31
JP2007516235A (ja) 2007-06-21
DE112004001659D2 (de) 2006-08-10
CA2542813C (en) 2011-08-30
RU2006116629A (ru) 2007-11-27
DK1678130T3 (da) 2008-12-01
PT1678130E (pt) 2008-10-08
RU2355685C2 (ru) 2009-05-20

Similar Documents

Publication Publication Date Title
EP4069691B1 (en) Substituted tetrahydrofurans as modulators of sodium channels
JP5940562B2 (ja) イオンチャネルのモジュレーターとしてのクロマン−スピロ環式ピペリジンアミド
EP2804868B1 (en) Pyran-spirocyclic piperidine amides as modulators of ion channels
EP1051394B1 (en) Potassium channel inhibitors
RU2383536C2 (ru) Производное триазола
EP2767531B1 (en) Cyclic n,n'-diarylthioureas and n,n'-diarylureas as androgen receptor antagonists, anti-cancer agent, method for producing and using same
KR20170033314A (ko) Ｆｓｈｒ의 조절제로서의 피라졸 화합물 및 이의 용도
UA82907C2 (en) Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromium-6-yl-derivatives, process and intermediates for the preparation thereof and drugs containing said compounds
FR2665441A1 (fr) Derives de la n-sulfonyl indoline, leur preparation, les compositions pharmaceutiques en contenant.
CA2028668A1 (en) Compounds
FR3066761A1 (fr) Nouveaux composes inhibiteurs des canaux ioniques
US7534903B2 (en) Use of amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl-compounds in the treatment of cardiac arrhythmia and other disease states
CN114516832A (zh) 一种微管蛋白抑制剂及其制备方法与应用
WO2014022639A1 (en) Solid forms of (4-isopropoxy-3-methoxyphenyl)(2'-methyl-6'-(trifluoromethyl)-3',4'-dihydro-2'h-spiro[piperidine-4,1'-pyrrolo[1,2-a]pyrazine]-1-yl)methanone
EP3218363B1 (en) Sulfonyl piperidine derivatives and their use for treating prokineticin mediated gastrointestinal disorders
CZ306998A3 (cs) Chromany, substituované sulfonamidovou skupinou, způsob jejich přípravy, jejich použití jako léčiv, jakož i farmaceutické prostředky, které je obsahují
US5962454A (en) Neovascularization inhibitor
RU2823231C1 (ru) Соединение-антагонист PD-L1
MX2007011198A (es) Derivados de los 2-(4-sulfonilamino)-3-3hidroxi-3,4-dihidro-2h- croman -6- ilo sustituidos con aminoalquil-amidometilo y medicamentos que contienen estos compuestos.
WO2026006674A1 (en) Heteroaryl compounds for the treatment of pain
WO2025067239A1 (zh) 驱动蛋白kif18a抑制剂及其应用
HK40121637A (en) Substituted tetrahydrofurans as modulators of sodium channels
KR820001541B1 (ko) 치환 몰라노린 유도체의 제조방법
EP2711367A1 (en) New spiroepoxide tetrahydrobenzo-triazoles and -imidazoles and their use as MetAP-II inhibitors
WO2019087163A1 (en) Polycyclic herg activators